Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
European Wax Center, a leading US waxing services franchisor, has introduced the Golden Orchard Body Butter and Body Polish, limited-edition fall skincare products designed to hydrate, exfoliate, and nourish skin while reducing hair thickness between waxes, expanding its SLOW Hair Minimizing System.
Cardiff Oncology announced that their Ph.D. Mani Mohindru will present at the 8th Annual RAS-Targeted Drug Development Summit and participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference. The company focuses on developing PLK1 inhibition therapies, including its lead candidate onvansertib, targeting RAS-mutated…
G-III Apparel Group reported second quarter fiscal 2027 net income per diluted share of $0.46, surpassing guidance and nearly doubling last year's $0.25. Despite a 10% decline in net sales due to Calvin Klein and Tommy Hilfiger license losses, gross margins expanded by 440 basis points. The company completed the acquisition of Marc Jacobs, targetin…
Maze Therapeutics, a clinical-stage biopharmaceutical company focused on small molecule precision medicines for kidney and metabolic diseases, announced that management will participate in three investor conferences in early to mid-September 2026, including Wells Fargo Healthcare Conference, Citi Biopharma Summit, and HC Wainwright Global Investmen…
TScan Therapeutics announced a strategic reorganization to concentrate resources on developing in vivo engineered TCR-T cell therapies for solid tumors, advancing two candidates toward IND-enabling studies and planned Phase 1 trials by late 2027. Due to insufficient capital, the company has paused enrollment in the Phase 3 ALLOHA-2 study for TSC-10…
Tilray Brands, Inc. announced that due to strong consumer demand, its Popsicle Hard Firecracker flavor, originally a limited-edition seasonal product, will become a permanent offering in the Popsicle Hard malt beverage lineup. This move reflects the brand's strategy to leverage nostalgia-driven flavors to capture growth in the adult flavored bevera…
Ollie’s Bargain Outlet Holdings, Inc. announced its second quarter fiscal 2026 financial results, revealing a 9.1% increase in net sales to $741.3 million driven by new store openings and growth in loyalty members. Comparable store sales declined 1.8% due to challenging economic conditions, weather impact, and a competitive promotional environment.…
GXO Logistics, the world's largest pure-play contract logistics provider, announced that its executive leadership will participate in upcoming investor conferences, including the Jefferies Global Industrials Conference and the Morgan Stanley 14th Annual Laguna Conference. The company will showcase its strategies and business updates through present…
EyePoint, Inc. (Nasdaq: EYPT), a clinical-stage biopharmaceutical company focused on retinal diseases, announced its active participation in several upcoming investor conferences and The Retina Society 59th Annual Scientific Meeting, where it will present data on its lead product candidate DURAVYU (EYP-1901). DURAVYU is a sustained delivery treatme…
Fortrea has signed a definitive agreement to acquire the Early Phase Services division of Worldwide Clinical Trials, including a clinical pharmacology unit, bioanalytical laboratory, and biospecimen storage facilities in Texas. This acquisition strengthens Fortrea’s integrated clinical development platform from first-in-human studies through Phase …
Opus Genetics announced it will present topline data from Cohort 1 of its Phase 1/2 study of OPGx-BEST1 gene therapy targeting BEST1-related inherited retinal diseases. The data presentation is scheduled for September 9, 2026, followed by full clinical datasets at major ophthalmology conferences. OPGx-BEST1 uses an AAV vector to deliver a functiona…
FactSet will release its financial results for the fourth quarter of fiscal 2026 on September 30, 2026, followed by a conference call to discuss the results. The earnings presentation and a replay will be accessible on the company's Investor Relations website.
VEON Ltd. will release its consolidated financial and operating results for Q3 2026 on November 6, 2026, followed by a conference call with senior management. Additionally, the company will hold a Capital Markets Day on November 16, 2026, to discuss strategic priorities, business performance, and long-term value creation.
CoinShares PLC has completed the acquisition of Bastion Asset Management, integrating Bastion's systematic investment team and strategies into its Active Alternative Strategies business. The acquisition enhances CoinShares' ability to offer both passive and active digital asset investment strategies, broadening its institutional platform and produc…
Sagimet Biosciences, a clinical-stage biopharmaceutical company focused on novel therapeutics targeting metabolic and fibrotic pathways, announced its management participation at the Cantor 2026 Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference in New York. The events include a fireside chat to be held an…
Tonix Pharmaceuticals announced participation in Cantor's 2026 Global Healthcare Conference featuring a fireside chat with CEO Dr. Seth Lederman. The company showcased its focus on CNS disorders, infectious diseases, immunology, and rare diseases with marketed products including TONMYA® for fibromyalgia and migraine treatments, along with advancing…
Aeluma, a NASDAQ-listed semiconductor company specializing in scalable photonic and electronic technologies, announced it will release its fourth quarter and fiscal year 2026 financial results after market close on September 16, 2026. The company will host an investor conference call the same day to discuss its financial performance and business ou…
Can-Fite BioPharma reports that overall survival in its ongoing pivotal Phase III trial of Namodenoson for advanced hepatocellular carcinoma (HCC) is longer than initially expected, prompting plans to advance the interim analysis. While the trial remains blinded, this positive signal may indicate potential clinical benefit for patients with substan…
Wrap Technologies announced the development of a new law enforcement doctrine and training curriculum designed to operationalize de-escalation utilizing its BolaWrap 150 device, recently classified by the ATF as an instrument of restraint rather than a firearm. The company has submitted the curriculum for independent validation and California Peace…
MediWound Ltd., a biotech company specializing in enzymatic, non-surgical therapies for tissue repair, announced that CEO Ofer Gonen will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City. The event includes a fireside chat moderated by a senior healthcare analyst, providing a platform to discuss company devel…
Rapport Therapeutics, a clinical-stage biotech company focused on precision small molecule medicines for neurological and psychiatric disorders, will participate in upcoming investor events including the Cantor Global Healthcare Conference and TD Cowen Neuropsychiatry Summit. Management will discuss its RAP technology platform and lead drug candida…
Lexeo Therapeutics, a clinical-stage genetic medicine company focused on cardiovascular disease treatments, announced its management team's participation in two investor conferences in September 2026. These engagements aim to update investors on the company's progress and pipeline developments, including novel therapies targeting genetic causes of …
European and U.K. wholesale natural gas benchmarks rallied to their highest levels since 2023 after a fresh escalation of military activity in the Persian Gulf and an intensifying supply squeeze. Traders said disruptions to commercial transit through the Strait of Hormuz, combined with below-average regional storage refill rates, have elevated risk…
Reliance, Inc., a leading global diversified metal solutions provider and the largest metals service center company in North America, announced that its CEO and COO will participate in the 2026 Jefferies Global Industrials Conference. The presentation will be webcast live and available for replay, highlighting the company's operations and strategic…
A fresh round of strikes in the Iran conflict has sent crude and natural gas prices higher, intensifying pressure on global government bond markets. The jump in energy costs is concentrating stress on 10-year benchmark yields - a move that has spilled into equities and currencies ahead of likely rate increases from major central banks this month.
